SRRK Scholar Rock Holding Corporatio
$43.25▲ +1.79%
Healthcare
Other
After hours
$42.93▼ -0.75%
Oct 28, 4:46 PM ET
Volume 1.67M
Avg Volume (10D) 1.90M
Key Metrics & Fundamentals
Market Cap
$5.27B
P/E Ratio
–
Div Yield
0.00%
52W Range
27.07 - 61.76
% vs 50 MA
-11.63%
% vs 200 MA
-10.29%
RSI-14
46.5
MACD Histogram
+0.5700
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$70.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$105.08M
COGS
–
Operating Exp
$108.90M
Operating Income
-$108.90M
EBIT
-$108.90M
Pretax Income
-$109.90M
Net Income
-$109.90M
EPS (Diluted)
-0.84
Price & Volume History
Loading chart…
Recent News
Scholar Rock Holding Insider Bought Shares Worth $11,999,922, According to a Recent SEC Filing
MT Newswires · Oct 28, 2026 4:09 AM ET
Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
Business Wire · Oct 20, 2026 8:00 AM ET
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 16, 2026 4:15 PM ET
EMA Resubmission for Apitegromab Might Change The Case For Investing In Scholar Rock Holding (SRRK)
Simply Wall St. · Oct 15, 2026 9:20 PM ET
Scholar Rock Resubmits Apitegromab Application in EU for Spinal Muscular Atrophy
MT Newswires · Oct 8, 2026 9:11 AM ET
Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Business Wire · Oct 8, 2026 8:00 AM ET
3 drug targets pharma is betting on next
Pharma Voice · Oct 2, 2026 9:00 AM ET
FDA Decision Watch: BMY, EGTX Face Key Decisions This Week As BFRI, SRRK And MIRM Score Early Approvals
Stocktwits · Sep 28, 2026 6:44 AM ET
Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says
MT Newswires · Sep 25, 2026 12:35 PM ET
Truist Lifts Price Target on Scholar Rock Holding to $77 From $76, Keeps Buy Rating
MT Newswires · Sep 24, 2026 7:10 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SRRK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.